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Background. The study aimed to examine sex diﬀerences in healthcare use before and after widowhood to investigate whether
reduced healthcare use among widowers compared with widows may partially explain excess mortality and more adverse health
outcomes among men than women after spousal loss. Methods. All individuals alive and aged at least 60 years in 1996 and who
became widowed in the period from 1996 to 2003 were selected from the 5% sample of the total Danish population and all
Danish twins. The healthcare use was assessed as the average daily all-cause and major system-speciﬁc medication use and the
average annual number of visits to general physicians (GPs). Results. The average daily use of all-cause and major system-speciﬁc
medications, as well as the number of GP visits increased over thep e r i o df r o m1y e a rb e f o r ea n du pt o5y e a r sa f t e ras p o u s e ’ s
death, but there were no sex-speciﬁc patterns in the trajectories of medication use and number of GP visits after conjugal loss.
Conclusion. We found little support for the hypothesis that reduced healthcare use contributes to the explanation of more adverse
health outcomes after conjugal loss in men compared with women in Denmark.
1.Introduction
There is a mounting research literature showing a mortality
and health disadvantage after spousal bereavement [1].
Elevated risks of death after conjugal loss among middle-
and old-aged persons were found for all-cause mortality and
most major causes of death, such as cancers, cardiovascular
diseases (CVD), respiratory diseases, accidents, and violence
in Finland, UK, and the US [2–5]. This excess mortality
among the bereaved usually occurs within the ﬁrst six
months following the death of a spouse [3, 4]; however,
some studies have suggested that it remains high many
years after bereavement [6, 7]. In addition to mortality, the
loss of a spouse was found to be associated with higher
levels of depressive symptoms, poorer physical and cognitive
function, worse self-rated health, and an increased risk of
institutionalization in the US, Chinese, and Finish middle-
and old-aged surviving spouses [8–12]. The adverse eﬀects2 Journal of Aging Research
of spousal loss on health and mortality were independent of
socioeconomic and health characteristics [8, 10, 13].
Previous research has shown signiﬁcant sex diﬀerences in
the widowhood eﬀects: greater adverse eﬀects on mortality
and health have been found among widowers [1, 3, 9, 10,
14, 15]. Nevertheless, a few studies reported excess all-cause
mortality after spousal loss to be very similar in men and
women [6, 16]. There is also conﬂicting evidence regarding
sex diﬀerences in the eﬀects of bereavement on depressive
symptoms and other dimensions of mental health [12, 14,
17].
Although the literature on widowhood eﬀects on health
and mortality in Denmark is limited, available data suggest
that, as in the predominantly North American literature, the
excess mortality is substantially higher among middle-aged
and elderly widowers than among the same-aged widows [7,
18, 19]. A register study among the total Danish population
aged 50 and over found that the oldest-old widowers had
substantiallyhighersuiciderisksthanthesame-agedwidows,
but the sex diﬀerences were less pronounced in the younger
age groups [7]. However, another register-based study in
Denmark among 25–60 years old individuals revealed that
therelativerisk ofsuicideandriskofdeathfromothercauses
after conjugal loss was substantially higher in men than in
women. A study based on the total Danish twin population
aged 50 to 70 indicated higher hazard rates after the death
of a spouse and co-twin among men than among women,
although the timing patterns were similar in both sexes
[19]. Evidence for sex diﬀerences in widowhood eﬀects on
cancer incidence and cancer mortality in other Scandinavian
countries is inconclusive [20, 21]. Although cancer incidence
changed in the same direction among Swedish widowers and
widows, the risk of esophageal, lung, and all cancers was
higher in men than in women, whereas the risk of pancreatic
cancersigniﬁcantlyincreasedandtheriskofmelanoma,skin,
cancer and non-Hodgkin’s disease signiﬁcantly decreased in
women only [20].
Several explanations have been proposed for gender
diﬀerences in health and morality following bereavement.
First, as most studies have generally demonstrated greater
longevity and health beneﬁts for married men than for
married women, it has been suggested that conjugal loss
may be more stressful for widowers compared with widows
[15]. However, it is still unclear why physiological changes
underlying reactivity to stressful life events should diﬀer by
sex. Second, it has been suggested that the adverse eﬀects of
widowhood on health and mortality may be due to the loss
of social, material, and task support [3, 15]. Finally, there
has been some investigation of the impact of losing a spouse
on health behaviors, such as smoking, alcohol consumption,
diet, and interaction with healthcare services [22–26].
Despite growing research on the adverse widowhood
eﬀects on health and mortality, existing studies that exam-
inedsexdiﬀerencesinlifestylebehaviorsandsocialassistance
as explanations for sex diﬀerential eﬀect of widowhood on
health and mortality had small sample size [23, 25, 27, 28],
short follow-up period [29], excluded old-aged individuals
[24], had no information on nonrespondents [9], and were
based on cross-sectional data [30] .S t u d i e so nt h ec h a n g e si n
health maintaining behavior around the time of widowhood
as underlying mechanism for adverse bereavement eﬀect on
health and mortality are scarce [26, 31].
The present study aimed to investigate sex diﬀerences
in short- and longer-term healthcare use following conjugal
loss by comparing medication and primary healthcare use
before and after a spouse’s death. We hypothesized that after
a spouse’s death elderly men will reduce medication use
and visits to general practitioners (GPs), while women will
maintain or increase their healthcare utilization compared to
their preloss level. If so, such reduction in medication use
and number of GP visits among men may contribute to the
explanation of more adverse health outcomes after conjugal
loss among men than women.
2.MaterialsandMethods
In April 1968, the Civil Registration System (CRS) was
introduced in Denmark, where each resident is assigned
the 10-digit unique personal identiﬁer, the Central Personal
Register (CPR) number. The CPR-number was used to
link the diverse computerized registers covering the total
Danish population: Danish Demographic Database (DDB)
(demographics, residence, migration, and civil status since
1968), the Prescription Medicine Register (medicine-related
information since 1995), the Health Insurance Register
(information on primary care services since 1997), and the
Danish Twins Register (demographics, residency, zygosity).
Prior studies have proved the register data in Denmark to be
reliable and valid with no linkage problems among registers
[32–34].
The study is based on the 5% sample of the total Danish
population and all Danish twins identiﬁed through the CRS
and the Danish Twin Register, respectively. The total twin
population was included to increase the sample size of older
people, especially men, who became widowed in the period
from January 1, 1996 to January 31, 2003. Previous research
in Denmark demonstrated that twins are representative of
general populations in terms of health trajectories, psycho-
logical function, and all-cause and cardiovascular mortality
and, thus, are good population models for epidemiological
anddemographicresearch[35,36].Additionally,theanalysis
of age-speciﬁc death rates in the twin and 5% population by
marital status in 1998 and 2000 showed patterns similar to
that in the total Danish population (data not shown).
All individuals alive and aged at least 60 years by
January 1, 1996 were initially selected. Further we selected all
individualswhobecamewidowedintheperiodfromJanuary
1, 1996 to January 31, 2003. This observation period was
chosen as the Prescription Medicine Register is only available
from1995onwards,andtheupdatedcivilstatuswasavailable
until January 31, 2003. Furthermore, the analysis of primary
healthcare use was restricted to the period from January
1, 1997 to January 31, 2003 because the Health Insurance
Register only began in 1997. Survival status was available
through December 2006.
The Prescription Medicine Register contains detailed
Anatomical Therapeutic Chemical classiﬁcation system
(ATC) codes of prescribed medications and their sublevels,Journal of Aging Research 3
Table 1: The frequency of all-cause and system-speciﬁc medication use within 1 year before and 1 year after widowhood.
ATC Age Men No. Women No.
Users before Users after
Men Women Men Women
No. % No. % No. % No. %
All-cause
60–69 521 1242 416 79.8 1022 82.3 418 80.2‡ 1081 87.0
70–79 925 1996 771 83.4† 1777 89.0 807 87.2‡ 1837 92.0
80+ 707 1030 619 87.6† 946 91.8 644 91.1‡ 975 94.7
ATC-C
60–69 521 1242 166 31.9 435 35.0 204 39.2 488 39.3
70–79 925 1996 399 43.1† 992 49.7 451 48.8‡ 1098 55.0
80+ 707 1030 387 54.8† 629 61.1 431 61.0 653 63.4
ATC-N
60–69 521 1242 210 40.3† 594 47.8 253 48.6‡ 768 61.8
70–79 925 1996 414 44.8† 1204 60.3 508 54.9‡ 1367 68.5
80+ 707 1030 399 56.4† 715 69.4 454 64.2‡ 783 76.0
ATC-R
60–69 521 1242 102 19.6† 299 24.1 113 21.7 315 25.4
70–79 925 1996 207 22.4† 526 26.4 217 23.5‡ 566 28.4
80+ 707 1030 177 25.0 255 24.8 192 27.2 266 25.8
ATC-A
60–69 521 1242 129 24.8 338 27.2 158 30.3 353 28.4
70–79 925 1996 284 30.7† 709 35.5 333 36.0 772 38.7
80+ 707 1030 292 41.3 461 44.8 342 48.4 497 48.3
ATC: Anatomical Therapeutic Chemical classiﬁcation system; ATC-C: cardiovascular system; ATC-N: nervous system; ACT-R: respiratory system; ATC-A:
alimentary tract and metabolism medications.
†P value < 0.05 for sex diﬀerence in the frequency of medication use before widowhood as obtained by chi-square test.
‡P value < 0.05 for sex diﬀerence in the frequency of medication use after widowhood as obtained by chi-square test.
datesofpurchase,dailydeﬁneddose(DDD),andotherdrug-
related information. The deﬁned daily dose of a medication
is based on the accepted average dose per 24 hours for that
medicinal product facilitating comparison of consumption
across diﬀerent medications [37]. All-cause medication use
was estimated within 1 year before and up to 5 years after
spousal death in the average daily deﬁned dose (DDD)
by dividing the total DDDs dispensed for all medications
combined within 1 year to 365.25 days. If a surviving spouse
diedwithinafollow-upyear,theaverageDDDwascalculated
by dividing the total DDD dispensed during that follow-
up year to the number of days survived. Because previous
studies showed sex diﬀerences in cause-speciﬁc medication
use, the medication use was also assessed for several major
system-speciﬁc medications (the anatomical main group
level 1): cardiovascular (ATC-C), nervous (ATC-N), respira-
tory(ATC-R),andalimentarytractandmetabolism(ATC-A)
medications.
The use of primary healthcare was assessed as the average
number of visits to GPs per year within 1 year before and
up to 4 years after spouse’s death. Similar to the estimation
of medication use, the average number of GP visits in the
follow-up years was adjusted to the time at risk. Additional
analyses of all-cause and system-speciﬁc medication use
before and after widowhood among individuals conditional
on their survival to the third and ﬁfth follow-up years were
conducted to investigate whether selective dropout due to
death has an eﬀect on the trajectories of healthcare use.
The age at widowhood was categorized into three groups
to avoid small number of users in each age group: 60–69,
70–79, and 80+ years. Data analysis was performed using
IntercooledStata10.0.Chi-squaretestswereusedtoexamine
sex diﬀerences in the prevalence of medication use and
two independent sample t-tests were used to examine sex
diﬀerences in the average medication use and number of GP
visits 1 year before and 1 year after widowhood and the sex
gap in the change of healthcare use over the two time points.
3. Results
In total, there were 6421 individuals (66.5% women) aged
at least 60 by January, 1996 and became widowed during
the observation period from January 1, 1996 to January 31,
2003. Table 1 presents the percentage of men and women
taking prescription medications 1 year before and 1 year
after widowhood. In general, all-cause and system-speciﬁc
medication use 1 year before and 1 year after a spouse’s
death was more frequent among women than men (Table 1).
However, there were almost no gender diﬀerences in the
prevalence of ATC-A medications either one year before or
after widowhood (Table 1).
Table 2 shows the average DDD for ATC medications
dispensed 1 year before and after widowhood and the mean
diﬀerence in the average DDD between the two time periods.
Generally, the highest average DDD was found for ATC-C
medications, followed by ATC-N and ATC-R medicines in
both men and women. Women had higher average DDDs
for all-cause and ATC-N medications compared with men in
both the year before and after widowhood. Men, generally,
had higher average DDDs for ATC-R medications, although
sex diﬀerences were not always statistically signiﬁcant. The
sex-speciﬁcpatternsforATC-CandATC-Amedicationswere
less clear (Table 2). As expected, at each cross-sectional time
point, the average DDD was higher in older age groups.4 Journal of Aging Research
Table 2: Average daily deﬁned dose of all-cause and system-speciﬁc medications dispensed within 1 year before and 1 year after widowhood.
ATC Age
Before After Diﬀerence§
Men Women Men Women Men Women
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
All-cause
60–69 1.52 0.11 1.69 0.08 1.90 0.18 1.99 0.09 0.38 0.12 0.30 0.04
70–79 1.98† 0.09 2.46 0.07 2.51‡ 0.11 2.92 0.11 0.54 0.07 0.46 0.09
80+ 2.59 0.13 2.70 0.09 3.52 0.23 3.16 0.09 0.92∗ 0.18 0.46 0.06
ATC-C
60–69 0.67 0.07 0.59 0.05 0.84 0.12 0.70 0.06 0.17 0.09 0.11 0.02
70–79 0.82† 0.05 0.95 0.04 1.08 0.07 1.11 0.05 0.25 0.05 0.15 0.03
80+ 1.09 0.07 1.11 0.05 1.48 0.15 1.24 0.06 0.39∗ 0.12 0.13 0.03
ATC-N
60–69 0.26† 0.03 0.40 0.02 0.34‡ 0.04 0.52 0.03 0.08 0.02 0.13 0.01
70–79 0.32† 0.02 0.55 0.02 0.43‡ 0.03 0.70 0.03 0.12 0.02 0.15 0.02
80+ 0.44† 0.03 0.65 0.03 0.59‡ 0.04 0.77 0.03 0.15 0.03 0.12 0.02
ATC-R
60–69 0.22 0.04 0.17 0.02 0.26 0.05 0.19 0.02 0.04 0.03 0.01 0.01
70–79 0.21 0.03 0.21 0.02 0.25 0.03 0.24 0.02 0.04 0.01 0.02 0.01
80+ 0.17† 0.02 0.10 0.01 0.20‡ 0.02 0.12 0.01 0.02 0.01 0.02 0.01
ATC-A
60–69 0.12 0.02 0.15 0.01 0.15 0.02 0.17 0.01 0.03 0.02 0.02 0.01
70–79 0.18 0.02 0.21 0.01 0.23 0.02 0.27 0.03 0.04 0.01 0.06 0.03
80+ 0.27 0.03 0.29 0.02 0.41 0.04 0.36 0.02 0.14∗ 0.03 0.07 0.01
ATC: Anatomical Therapeutic Chemical classiﬁcation system; ATC-C: cardiovascular system; ATC-N: nervous system; ACT-R: respiratory system; ATC-A:
alimentary tract and metabolism medications; DDD: daily deﬁned dose.
∗P value < 0.05 for sex diﬀerences in the change of medication use before and after widowhood as obtained by two-sided t-test.
†P value < 0.05 for sex diﬀerence in the average DDD before widowhood as obtained by two-sided t-test.
‡P value < 0.05 for sex diﬀerence in the average DDD after widowhood as obtained by two-sided t-test.





















































































































































































Figure 2: System-speciﬁc medication use before and after widowhood.
The average DDD for all-cause and systems-speciﬁc ATC
medications increased from 1 year before to 1 year after
widowhood for both men and women (Table 2). The highest
increase in average DDD was observed in the ATC-C and
ATC-N medication use, followed by ATC-R and ATC-A
medications. The increase in all-cause, ATC-C, and ATC-R
medication use was slightly higher in men. However, the sex
diﬀerence was statistically signiﬁcant in the oldest age group
for all-cause (P-value = 0.02), ATC-C (P-value = 0.04), and
ATC-A (P = 0.02) medications.
Further analysis was done to examine whether there
was a sex-speciﬁc pattern in all-cause and system-speciﬁc
medication use up to 5 years after conjugal loss. The
average DDD for all-cause medications increased between
the year before and the third or fourth year following wid-
owhood and remained almost constant or slightly decreased
afterwards (Figure 1). Similar patterns were indicated for
system-speciﬁc medication use, although with much smaller
variations over time (Figure 2). However, there was no sex-
speciﬁc pattern in the change of all-cause and systems-
speciﬁc medication use over 1 year before and up to 5
years after widowhood. Among system-speciﬁc medications,
the most pronounced changes were observed for ATC-C
agents, except for the 60–69 years old age group, followed by
ATC-N and ATC-A medications. The increase in the ATC-N
medication use seems to be steeper within the ﬁrst year after
widowhood, but the pattern was similar in both sexes and all
age groups. The smallest changes over the follow-up period
were indicated for ATC-R medication use.
Analogous ﬁndings were obtained when the average
number of GP visits per year was considered as an indicator
of healthcare utilization (Figure 1). Women had slightly
more GP visits in all age groups compared with men. The
average number of visits increased with advancing age, but
these changes were similar in men and women. Similar
patterns were indicated when the median number of GP
visits was considered.
To investigate whether selective dropout due to death
has an eﬀect on the trajectories of healthcare use, we
analyzed all-cause and system-speciﬁc medication use and
number of GP visits before and after widowhood among
individuals conditional on their survival to the third and
ﬁfth follow-up years. The trajectories for all-cause (Figure 3)
and system-speciﬁc medication use remained unchanged
when the analysis was restricted to three- and ﬁve-year





































































Figure 3: All-cause medication use among 3- and 5-years survivors.
unaltered when the change in medication use 1 year before
and after widowhood was evaluated among users only or
when medication use was estimated for several therapeutic
subgroups (e.g., psycholeptics, psychoanaleptics, cardiac
therapy, diuretics, beta blocking agents, calcium channels
blockers, and agents acting on rennin-angiotensin system)
(data available on request).
4. Discussion
The present study aimed at comparing medication and pri-
mary healthcare use around the time of widowhood among
men versus same-aged women. It showed that all-cause and
major medication use, as well as primary healthcare use,
increased shortly after conjugal loss, as well as in the 3-4
years following spousal bereavement, and remained constant
or slightly decreased thereafter. The trajectories of all-cause
and system-speciﬁc medication use and the annual number
of GP visits over the period from 1 year before and up to
5 years after conjugal loss were similar in men and women.
Therefore, we found little support for the hypothesis that
widowers reduce medication use or visits to GPs, while
widows utilize healthcare services to a degree similar to that
of a preloss level. The increasing number of GP visits and all-
cause and system-speciﬁc medication use is likely to reﬂect
the eﬀect of age on the healthcare use rather than the eﬀect
of spousal loss.
Compared to the growing research on widowhood-
mortalityassociation,thenumberofstudiesthatinvestigated
the underlying mechanisms responsible for poor outcomes
following the death of a spouse, and, in particular, the
reasons why widowers fare worse than widows is less
extensive. Thompson and colleagues revealed that although
within 2-month period bereaved persons aged 55–83 years
had increased medication use, more severe illness, and worse
perceived general health, the number of physician visits and
hospitalizations was similar in bereaved and nonbereaved
groups [29]. The authors found no sex diﬀerences in the
increasedriskofmedicationuse,althoughwomenweremore
likely to report new and/or deteriorated health compared
with men regardless of marital status. Another US study
found that old-aged widowed persons with traumatic grief
were less likely to use all types of healthcare services within
2 months after spouse’s death compared with the bereaved
subjects without traumatic grief [28]. Williams found that
widowhood increased the risk of having unhealthy lifestyle
behavior, developing a serious illness, and reporting worse
general health only among those widowed persons who had
a substantial decline in the frequency of health reminders
[25]. Transition to widowhood was found to increase the
ﬁrst-time use of domiciliary care services among 70 years
and over participants of the British Household Panel Survey
[38]. However, no sex diﬀerences in the change of healthcare
use associated with widowhood were reported in most
studies.ArecentstudyamongMedicarebeneﬁciariesshowed
substantial drop in obtaining preventive services, such as
diabetic monitoring, cancer screening, and vaccination, butJournal of Aging Research 7
considerable increase in the rates of preventable hospi-
talization and early readmissions [26]. Like in our study,
there were little gender diﬀerences in obtaining preventive
services, although widowed men had substantially higher
rates of preventable hospitalizations and early readmissions
than widows and no long-term detrimental eﬀects of spousal
loss on individual abilities to obtain preventive healthcare
services were indicated [26].
The present study adds to the previous research evidence
in Denmark and other Nordic countries [39, 40] showing
that all-cause and system-speciﬁc medication use was more
frequent and the average daily dose for all-cause and nervous
system medications was higher among women compared
with same-aged men. The average daily use of respiratory
medications was slightly higher among men, whereas no sex-
speciﬁc pattern was observed for ATC-C medication use.
A major strength of this study is the size, represen-
tativeness, and completeness of the Danish register data
and its longitudinal nature that enabled us to examine sex
diﬀerences in medication and primary healthcare use over
a longer follow-up period after the event. Because the data
on medication and primary healthcare use were obtained for
all individuals from the 5% population sample and the twin
population aged 60+ by January 1, 1996 and who became
widowedintheperiodfrom1996to2003,therewasnoroom
for selection bias due to nonparticipation or loss to follow-
up inherent in longitudinal surveys. The present study had
as u ﬃciently large sample size and, thus, good power to
detect sex-speciﬁc pattern in health behaviors before and
after spousal bereavement.
The analysis of medication use and number of GP visits
over the follow-up years reﬂects both the eﬀect of age on the
healthcareutilizationandtheeﬀectofconjugalbereavement.
However, it is unlikely to bias the analysis of male-female
diﬀerences in healthcare utilization before and after spouse’s
death. Clearly, our ﬁndings may be country-speciﬁc and may
not be generalizable to other settings. It has been found that
Sweden and Denmark have greater gender equality in the
division of household labor compared with Greece or Spain
[41]. Possibly, men in northern EU countries depend less on
their wives for regulating health behaviors than in the more
traditional southern EU. Further research should attempt to
replicate this study in other populations where register data
are available.
5. Conclusions
This study shows no sex diﬀerence in the trajectories of
medication and primary healthcare use within 1 year before
and up to 4 years after spouse’s death. Therefore, this Danish
study found no support for the hypothesis that reduced
medication and primary healthcare use contribute to the
explanation of more adverse health outcomes after conjugal
loss in men compared with women in Denmark.
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